Increased tau phosphorylation at the Ser396 epitope after amyloid beta-exposure in organotypic cultures

NeuroReport

Volumn 17, Issue 9, 2006, Pages 907-911

  Johansson, Sara ^a,b   Jämsä, Anne ^a,b   Vasänge, Mervi ^a   Winblad, Bengt ^b   Luthman, Johan ^c   Cowburn, Richard F ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Serono International SA   (Switzerland)

Author keywords

Amyloid beta; Glycogen synthase kinase 3 ; Neurodegeneration; Organotypic cultures; Tau phosphorylation

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; EPITOPE; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; TAU PROTEIN; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STATISTICAL SIGNIFICANCE; TISSUE CULTURE;

AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; EPITOPES; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SERINE; TAU PROTEINS; TIME FACTORS;

EID: 33745010910     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000221844.35502.29     Document Type: Article

References (25)

1. Hardy J, Selkoe D. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-356.
2. Alonso AC, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci 1997; 94:298-303.
3. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (Berlin) 2002; 103:26-35.
4. Liu F, Iqbal K, Grundke-Iqbal I, Gong CX. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett 2002; 530:209-214.
5. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 1999; 58:1010-1019.
6. Tseng HC, Zhou Y, Shen Y, Tsai LH. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett 2002; 523:58-62.
7. Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, et al. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 1998; 31:317-323.
8. Götz J, Schild A, Hoerndli F, Pennanen L. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 2004; 22:453-465.
9. Oddo S, Caccamo A, Sheperd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003; 39:409-421.
10. Allen YS, Devanathan PH, Owen GP. Neurotoxicity of beta-amyloid protein: cytochemical changes and apoptotic cell death investigated in organotypic cultures. Clin Exp Pharmacol Physiol 1995; 22:370-371.
11. Gähwiler BH. Organotypic monolayer cultures of nervous tissue. J Neurosci Methods 1981; 4:329-342.
12. Johansson S, Radesäter A-C, Cowburn RF, Thyberg J, Luthman J. Modelling of amyloid β-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats. Exp Brain Res 2006; 168:11-24.
13. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 1995; 64:253-265.
14. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991; 37:173-182.
15. Schmued LC, Hopkins KJ. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000; 874:123-130.
16. Bruce AJ, Malfroy B, Baudry M. Beta-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci USA 1996; 93:2312-2316.
17. Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 1998; 436:28-34.
18. Ferrari A, Hoerndli F, Baechi T, Nitsch RM, Gotz J. Beta-amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 2003; 278:40162-40168.
19. Cedazo-Mínguez A, Popescu BO, Blanco-Millán JM, Akterin S, Pei JJ, Winblad B, et al. Apolipoprotein E and β-amyloid (1-42) regulation of glycogen synthase kinase-3β. J Neurochem 2003; 87:1152-1164.
20. Ishiguro K, Omori A, Takamatsu M, Sato K, Arioka M, Uchida T, et al. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci Lett 1992; 148:202-206.
21. Saito T, Onuki R, Fujita Y, Kusakawa G, Ishiguro K, Bibb JA, et al. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J Neurosci 2003; 23:1189-1197.
22. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000; 405:360-364.
23. Otth C, Concha II, Arendt T, Stieler J, Schliebs R, Gonzalez-Billault C, et al. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 2002; 4:417-430.
24. Tandon A, Yu H, Wang L, Rogaeva E, Sato C, Chishti MA, et al. Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. J Neurochem 2003; 857:572-581.
25. Takahashi M, Tomizawa K, Ishiguro K. Distribution of tau protein kinase I/glycogen synthase-3β, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res 2000; 857:193-206.